Euclidean Capital
Latest statistics and disclosures from Euclidean Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VEU, VTV, INDA, FHTX, ORIC, and represent 96.31% of Euclidean Capital's stock portfolio.
- Added to shares of these 2 stocks: VTV (+$99M), VEU (+$30M).
- Started 1 new stock position in VTV.
- Euclidean Capital was a net buyer of stock by $130M.
- Euclidean Capital has $370M in assets under management (AUM), dropping by 55.23%.
- Central Index Key (CIK): 0001825034
Tip: Access up to 7 years of quarterly data
Positions held by Euclidean Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 12 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 59.5 | $220M | +15% | 3.0M | 73.56 |
|
| Vanguard Index Fds Value Etf (VTV) | 26.9 | $99M | NEW | 520k | 190.99 |
|
| Ishares Tr Msci India Etf (INDA) | 5.4 | $20M | 370k | 54.05 |
|
|
| Foghorn Therapeutics (FHTX) | 2.3 | $8.5M | 1.6M | 5.40 |
|
|
| Oric Pharmaceuticals (ORIC) | 2.2 | $8.1M | 989k | 8.18 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.9 | $3.3M | 2.6M | 1.25 |
|
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.8 | $2.8M | 4.1k | 681.92 |
|
|
| Rapt Therapeutics Com New (RAPT) | 0.8 | $2.8M | 82k | 33.87 |
|
|
| Alector (ALEC) | 0.6 | $2.0M | 1.3M | 1.56 |
|
|
| Surrozen Com New (SRZN) | 0.5 | $2.0M | 88k | 22.60 |
|
|
| Tenaya Therapeutics (TNYA) | 0.2 | $723k | 1.0M | 0.71 |
|
|
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.4k | 171k | 0.02 |
|
Past Filings by Euclidean Capital
SEC 13F filings are viewable for Euclidean Capital going back to 2020
- Euclidean Capital 2025 Q4 filed Feb. 17, 2026
- Euclidean Capital 2025 Q3 filed Nov. 14, 2025
- Euclidean Capital 2025 Q2 filed Aug. 14, 2025
- Euclidean Capital 2025 Q1 filed May 15, 2025
- Euclidean Capital 2024 Q4 filed Feb. 14, 2025
- Euclidean Capital 2024 Q3 filed Nov. 14, 2024
- Euclidean Capital 2024 Q2 filed Aug. 14, 2024
- Euclidean Capital 2024 Q1 filed May 15, 2024
- Euclidean Capital 2023 Q4 filed Feb. 14, 2024
- Euclidean Capital 2023 Q3 amended filed Dec. 1, 2023
- Euclidean Capital 2023 Q3 filed Nov. 14, 2023
- Euclidean Capital 2023 Q2 filed Aug. 14, 2023
- Euclidean Capital 2023 Q1 filed May 15, 2023
- Euclidean Capital 2022 Q4 filed Feb. 14, 2023
- Euclidean Capital 2022 Q3 filed Nov. 14, 2022
- Euclidean Capital 2022 Q2 filed Aug. 15, 2022